Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
about
Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.Evaluation of sulphasalazine in the treatment of spondyloarthropathies.Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis.Rheumatoid arthritis and gut related lymphocytes: the iteropathy concept.Conventional therapy for Crohn's diseaseEffects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialEfficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.Juvenile spondyloarthritis treatment recommendationsPeriodontal pathogens are likely to be responsible for the development of ankylosing spondylitis.Oral Anaerobic Bacteria in the Etiology of Ankylosing Spondylitis.Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides.Salazopyrin EN in rheumatoid arthritis.
P2860
Q33560570-17A1BBB9-B6E3-4995-AE30-8FD69DA8DDFDQ33560695-9184BAC4-D8CF-41C8-8E27-4CD59ED1B0DCQ33564938-09FFA4EF-F7C4-4F75-A33C-3DE5E8C41FF6Q33564950-B25D638C-108F-4516-9F32-15B3EF24CEA5Q33567171-818D3560-9791-420B-8E4E-7C11D6792AF1Q33570182-A3A00EF1-CEF0-442B-BABE-28BE32ED05DCQ33866982-F11682D9-7BEE-4F17-B026-689EE6B93059Q35537104-0FF4D75D-0F36-4E81-BC5E-675485498489Q35637863-767E054B-81C2-4A1A-AE77-71DCAD66B99EQ36004879-053936D6-B0F0-4C9C-9864-EE48ABD470ACQ38499216-E95F260B-193F-42A7-A930-BD7DB1449EB6Q39389171-93E185AC-F917-4B07-9E3F-95C0752CE4B1Q41235897-5DB33696-7E25-4716-A938-B88307CB3B89Q46309940-B281BB62-D2C1-4575-8F94-47BC018B927B
P2860
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
description
1986 nî lūn-bûn
@nan
1986 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@ast
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@en
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@nl
type
label
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@ast
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@en
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@nl
prefLabel
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@ast
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@en
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@nl
P2093
P2860
P1433
P1476
Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
@en
P2093
P2860
P304
P407
P577
1986-10-01T00:00:00Z